Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
Background: Schizophrenia causes significant neurocognitive impairment. Treatment with antipsychotics leads to improvement in psychopathology and neurocognitive functions. Aim: To see comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia. M...
Saved in:
Main Authors: | Sanya Sharma, Ajeet Sidana, Shivangi Mehta, Manoj Kumar Bajaj |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-10-01
|
Series: | Indian Journal of Psychiatry |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_303_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin for neurocognitive dysfunction in schizophrenia: a systematic review
by: Zhen-Juan Qin, et al.
Published: (2025-01-01) -
Reduction Behavior of Olanzapine and Its Differential Pulse Voltammetric Determination in Human Urine and Pharmaceuticals
by: Sultan Yağmur
Published: (2020-12-01) -
Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study
by: Olena Said, et al.
Published: (2024-11-01) -
Neurological and neurocognitive alterations by COVID-19
by: Charles Ysaacc Da Silva Rodrigues
Published: (2020-12-01) -
Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01)